Published in Adv Mater on November 21, 2011
Plug-and-play pairing via defined divalent streptavidins. J Mol Biol (2013) 0.94
A nanoscale force probe for gauging intermolecular interactions. Angew Chem Int Ed Engl (2012) 0.86
Monovalent Strep-Tactin for strong and site-specific tethering in nanospectroscopy. Nat Nanotechnol (2015) 0.78
Combination of Universal Mechanical Testing Machine with Atomic Force Microscope for Materials Research. Sci Rep (2015) 0.75
Reversible unfolding of individual titin immunoglobulin domains by AFM. Science (1997) 19.62
Adhesion forces between individual ligand-receptor pairs. Science (1994) 11.62
Energy landscapes of receptor-ligand bonds explored with dynamic force spectroscopy. Nature (1999) 10.45
Ligand binding: molecular mechanics calculation of the streptavidin-biotin rupture force. Science (1996) 8.19
Mechanical and chemical unfolding of a single protein: a comparison. Proc Natl Acad Sci U S A (1999) 7.74
Designing materials for biology and medicine. Nature (2004) 7.73
Intermolecular forces and energies between ligands and receptors. Science (1994) 7.44
Molecular dynamics study of unbinding of the avidin-biotin complex. Biophys J (1997) 6.93
Titins: giant proteins in charge of muscle ultrastructure and elasticity. Science (1995) 6.67
Mechanical unfolding intermediates in titin modules. Nature (1999) 6.12
A minimal peptide substrate in biotin holoenzyme synthetase-catalyzed biotinylation. Protein Sci (1999) 6.05
Crystal structure of core streptavidin determined from multiwavelength anomalous diffraction of synchrotron radiation. Proc Natl Acad Sci U S A (1989) 5.57
Structural origins of high-affinity biotin binding to streptavidin. Science (1989) 5.37
A reversible wet/dry adhesive inspired by mussels and geckos. Nature (2007) 5.26
Reverse engineering of the giant muscle protein titin. Nature (2002) 3.54
The mechanical hierarchies of fibronectin observed with single-molecule AFM. J Mol Biol (2002) 3.09
Nanospring behaviour of ankyrin repeats. Nature (2006) 3.02
THE PROPERTIES OF STREPTAVIDIN, A BIOTIN-BINDING PROTEIN PRODUCED BY STREPTOMYCETES. Arch Biochem Biophys (1964) 2.96
Hidden complexity in the mechanical properties of titin. Nature (2003) 2.51
Covalently functionalized nanotubes as nanometre-sized probes in chemistry and biology. Nature (1998) 2.49
Polysaccharide elasticity governed by chair-boat transitions of the glucopyranose ring. Nature (1998) 2.47
Molecular cloning and nucleotide sequence of the streptavidin gene. Nucleic Acids Res (1986) 2.30
Connectin/titin, giant elastic protein of muscle. FASEB J (1997) 2.26
Molecular nanosprings in spider capture-silk threads. Nat Mater (2003) 2.23
The relationship between ligand-binding thermodynamics and protein-ligand interaction forces measured by atomic force microscopy. Biophys J (1995) 2.15
Molecular interaction between the Strep-tag affinity peptide and its cognate target, streptavidin. J Mol Biol (1996) 2.10
Characterization and crystallization of core streptavidin. J Biol Chem (1987) 2.09
Single molecule force spectroscopy in biology using the atomic force microscope. Prog Biophys Mol Biol (2000) 1.87
Mutagenesis of a flexible loop in streptavidin leads to higher affinity for the Strep-tag II peptide and improved performance in recombinant protein purification. Protein Eng (1997) 1.85
Designed biomaterials to mimic the mechanical properties of muscles. Nature (2010) 1.80
Engineered chimeric streptavidin tetramers as novel tools for bioseparations and drug delivery. Biotechnology (N Y) (1995) 1.78
Titin/connectin and nebulin: giant protein rulers of muscle structure and function. Adv Biophys (1996) 1.76
Versatile cloning system for construction of multimeric proteins for use in atomic force microscopy. Protein Sci (2002) 1.67
Force and function: probing proteins with AFM-based force spectroscopy. Curr Opin Struct Biol (2009) 1.54
Atomic force microscopy: determination of unbinding force, off rate and energy barrier for protein-ligand interaction. Micron (2006) 1.40
Protein engineering approaches to biomaterials design. Curr Opin Biotechnol (2005) 1.30
Mechanochemistry: one bond at a time. ACS Nano (2009) 1.26
Atomic force microscopy of biochemically tagged DNA. Proc Natl Acad Sci U S A (1993) 1.24
Extremely high thermal stability of streptavidin and avidin upon biotin binding. Biomol Eng (1999) 1.22
Improved affinity of engineered streptavidin for the Strep-tag II peptide is due to a fixed open conformation of the lid-like loop at the binding site. Protein Sci (2002) 1.20
Engineering soluble monomeric streptavidin with reversible biotin binding capability. J Biol Chem (2005) 1.19
Influence of substrate binding on the mechanical stability of mouse dihydrofolate reductase. Biophys J (2005) 1.11
Streptavidins with intersubunit crosslinks have enhanced stability. Nat Biotechnol (1996) 1.11
Protein mechanics: from single molecules to functional biomaterials. Acc Chem Res (2010) 1.11
A streptavidin-protein A chimera that allows one-step production of a variety of specific antibody conjugates. Biotechnology (N Y) (1991) 1.08
Synthesis and activity of bivalent FKBP12 ligands for the regulated dimerization of proteins. Bioorg Med Chem (1998) 1.08
Materials science. Multitasking in tissues and materials. Science (2008) 1.07
Self-assembly and biomaterials. Nano Lett (2010) 0.99
Fast and forceful refolding of stretched alpha-helical solenoid proteins. Biophys J (2010) 0.95
Inhibitor binding increases the mechanical stability of staphylococcal nuclease. Biophys J (2011) 0.95
Applications of peptide and protein-based materials in bionanotechnology. Chem Soc Rev (2010) 0.90
Streptavidin-containing chimeric proteins: design and production. Methods Enzymol (2000) 0.79
Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature (2003) 5.94
Biological, clinical, and ethical advances of placebo effects. Lancet (2010) 5.36
The mechanical stability of ubiquitin is linkage dependent. Nat Struct Biol (2003) 4.66
A comprehensive review of the placebo effect: recent advances and current thought. Annu Rev Psychol (2008) 4.43
A common ankyrin-G-based mechanism retains KCNQ and NaV channels at electrically active domains of the axon. J Neurosci (2006) 4.10
Reverse engineering of the giant muscle protein titin. Nature (2002) 3.54
Nanospring behaviour of ankyrin repeats. Nature (2006) 3.02
Nav1.5 E1053K mutation causing Brugada syndrome blocks binding to ankyrin-G and expression of Nav1.5 on the surface of cardiomyocytes. Proc Natl Acad Sci U S A (2004) 2.88
Overt versus covert treatment for pain, anxiety, and Parkinson's disease. Lancet Neurol (2004) 2.73
New insights into the placebo and nocebo responses. Neuron (2008) 2.64
Ankyrin-based subcellular gradient of neurofascin, an immunoglobulin family protein, directs GABAergic innervation at purkinje axon initial segment. Cell (2004) 2.52
Placebo analgesia induced by social observational learning. Pain (2009) 2.18
How prior experience shapes placebo analgesia. Pain (2006) 2.15
Ankyrin-B coordinates the Na/K ATPase, Na/Ca exchanger, and InsP3 receptor in a cardiac T-tubule/SR microdomain. PLoS Biol (2005) 2.06
A cardiac arrhythmia syndrome caused by loss of ankyrin-B function. Proc Natl Acad Sci U S A (2004) 1.98
Mechanisms of the placebo response and their impact on clinical trials and clinical practice. Pain (2005) 1.81
Placebos and painkillers: is mind as real as matter? Nat Rev Neurosci (2005) 1.73
Ankyrin-G and beta2-spectrin collaborate in biogenesis of lateral membrane of human bronchial epithelial cells. J Biol Chem (2006) 1.72
Ankyrin-G is a molecular partner of E-cadherin in epithelial cells and early embryos. J Biol Chem (2007) 1.72
AnkyrinG is required to maintain axo-dendritic polarity in vivo. Proc Natl Acad Sci U S A (2009) 1.53
Ankyrin-B targets beta2-spectrin to an intracellular compartment in neonatal cardiomyocytes. J Biol Chem (2004) 1.52
A systematic review of adverse events in placebo groups of anti-migraine clinical trials. Pain (2009) 1.52
Lateral membrane biogenesis in human bronchial epithelial cells requires 190-kDa ankyrin-G. J Biol Chem (2004) 1.44
The ankyrin-B C-terminal domain determines activity of ankyrin-B/G chimeras in rescue of abnormal inositol 1,4,5-trisphosphate and ryanodine receptor distribution in ankyrin-B (-/-) neonatal cardiomyocytes. J Biol Chem (2002) 1.38
An ankyrin-based mechanism for functional organization of dystrophin and dystroglycan. Cell (2008) 1.37
Learning potentiates neurophysiological and behavioral placebo analgesic responses. Pain (2008) 1.35
How the number of learning trials affects placebo and nocebo responses. Pain (2010) 1.34
Recent developments in pain in dementia. BMJ (2005) 1.33
Ankyrin-G promotes cyclic nucleotide-gated channel transport to rod photoreceptor sensory cilia. Science (2009) 1.29
Developing nodes of Ranvier are defined by ankyrin-G clustering and are independent of paranodal axoglial adhesion. Proc Natl Acad Sci U S A (2002) 1.28
Inositol 1,4,5-trisphosphate receptor localization and stability in neonatal cardiomyocytes requires interaction with ankyrin-B. J Biol Chem (2004) 1.27
Alpha-adducin dissociates from F-actin and spectrin during platelet activation. J Cell Biol (2003) 1.25
Nocebo hyperalgesia: how anxiety is turned into pain. Curr Opin Anaesthesiol (2007) 1.23
L1-dependent neuritogenesis involves ankyrinB that mediates L1-CAM coupling with retrograde actin flow. J Cell Biol (2003) 1.23
Kv3.1b is a novel component of CNS nodes. J Neurosci (2003) 1.22
Localization and structure of the ankyrin-binding site on beta2-spectrin. J Biol Chem (2008) 1.21
Cholinergic augmentation of insulin release requires ankyrin-B. Sci Signal (2010) 1.21
Direct measurements of base stacking interactions in DNA by single-molecule atomic-force spectroscopy. Phys Rev Lett (2007) 1.18
Temporal changes in movement time during the switch of the stimulators in Parkinson's disease patients treated by subthalamic nucleus stimulation. Eur Neurol (2003) 1.15
Ank3-dependent SVZ niche assembly is required for the continued production of new neurons. Neuron (2011) 1.13
Pain in dementia. Pain (2009) 1.12
Isoform specificity of ankyrin-B: a site in the divergent C-terminal domain is required for intramolecular association. J Biol Chem (2005) 1.12
Activation likelihood estimation meta-analysis of brain correlates of placebo analgesia in human experimental pain. Hum Brain Mapp (2011) 1.10
Neural bases of conditioned placebo analgesia. Pain (2010) 1.08
A new activity of doublecortin in recognition of the phospho-FIGQY tyrosine in the cytoplasmic domain of neurofascin. J Neurosci (2002) 1.08
Molecular dynamics simulations of forced conformational transitions in 1,6-linked polysaccharides. Biophys J (2004) 1.05
Detecting ultraviolet damage in single DNA molecules by atomic force microscopy. Biophys J (2007) 1.05
Ankyrin-based cardiac arrhythmias: a new class of channelopathies due to loss of cellular targeting. Curr Opin Cardiol (2005) 1.04
Expectation modulates the response to subthalamic nucleus stimulation in Parkinsonian patients. Neuroreport (2002) 1.04
Adducin promotes micrometer-scale organization of beta2-spectrin in lateral membranes of bronchial epithelial cells. Mol Biol Cell (2007) 1.04
Expectation enhances autonomic responses to stimulation of the human subthalamic limbic region. Brain Behav Immun (2005) 1.03
Placebo analgesia and the heart. Pain (2003) 1.03
Ankyrins. J Cell Sci (2002) 1.01
Ankyrin-B syndrome: enhanced cardiac function balanced by risk of cardiac death and premature senescence. PLoS One (2007) 1.00
The placebo response: neurobiological and clinical issues of neurological relevance. Prog Brain Res (2009) 1.00
Cysteine 70 of ankyrin-G is S-palmitoylated and is required for function of ankyrin-G in membrane domain assembly. J Biol Chem (2012) 1.00
Ankyrin-B interactions with spectrin and dynactin-4 are required for dystrophin-based protection of skeletal muscle from exercise injury. J Biol Chem (2010) 1.00
Pain anticipation: an activation likelihood estimation meta-analysis of brain imaging studies. Hum Brain Mapp (2014) 0.99
Isoform specificity among ankyrins. An amphipathic alpha-helix in the divergent regulatory domain of ankyrin-b interacts with the molecular co-chaperone Hdj1/Hsp40. J Biol Chem (2004) 0.99
Mechanical unfolding of an ankyrin repeat protein. Biophys J (2010) 0.99
E-cadherin polarity is determined by a multifunction motif mediating lateral membrane retention through ankyrin-G and apical-lateral transcytosis through clathrin. J Biol Chem (2013) 0.98
Pulling geometry-induced errors in single molecule force spectroscopy measurements. Biophys J (2007) 0.95
Atomic force microscopy captures MutS tetramers initiating DNA mismatch repair. EMBO J (2011) 0.95
Placebos and treatment of pain. Pain Med (2004) 0.95
Placebo-related effects in clinical trials in schizophrenia: what is driving this phenomenon and what can be done to minimize it? Int J Neuropsychopharmacol (2012) 0.95
Ankyrin-B is required for coordinated expression of beta-2-spectrin, the Na/K-ATPase and the Na/Ca exchanger in the inner segment of rod photoreceptors. Exp Eye Res (2008) 0.95
Fast and forceful refolding of stretched alpha-helical solenoid proteins. Biophys J (2010) 0.95
Inhibitor binding increases the mechanical stability of staphylococcal nuclease. Biophys J (2011) 0.95
Elastic properties of single amylose chains in water: a quantum mechanical and AFM study. J Am Chem Soc (2004) 0.93
The top-down influence of ergogenic placebos on muscle work and fatigue. Eur J Neurosci (2008) 0.92
Defects in ankyrin-based cellular pathways in metazoan physiology. Front Biosci (2005) 0.91
The ammonium transporter RhBG: requirement of a tyrosine-based signal and ankyrin-G for basolateral targeting and membrane anchorage in polarized kidney epithelial cells. J Biol Chem (2004) 0.90
Antioxidant effects of diallyl trisulfide on high glucose-induced apoptosis are mediated by the PI3K/Akt-dependent activation of Nrf2 in cardiomyocytes. Int J Cardiol (2013) 0.90
Single molecule mechanical manipulation for studying biological properties of proteins, DNA, and sugars. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2013) 0.90
UVA generates pyrimidine dimers in DNA directly. Biophys J (2009) 0.90
Ankyrin-G regulates inactivation gating of the neuronal sodium channel, Nav1.6. J Neurophysiol (2006) 0.89
Placebo mechanisms across different conditions: from the clinical setting to physical performance. Philos Trans R Soc Lond B Biol Sci (2011) 0.89
What do you expect from this treatment? Changing our mind about clinical trials. Pain (2007) 0.88
Nanomechanical control of glucopyranose rotamers. J Am Chem Soc (2004) 0.88
Mechanical unfolding of ubiquitin molecules. J Chem Phys (2005) 0.87
Full reconstruction of a vectorial protein folding pathway by atomic force microscopy and molecular dynamics simulations. J Biol Chem (2010) 0.86
A nanoscale force probe for gauging intermolecular interactions. Angew Chem Int Ed Engl (2012) 0.86
Direct detection of inter-residue hydrogen bonds in polysaccharides by single-molecule force spectroscopy. Angew Chem Int Ed Engl (2005) 0.85
Pain perception and tolerance in patients with frontotemporal dementia. Pain (2010) 0.84
Ankyrin-based patterning of membrane microdomains: new insights into a novel class of cardiovascular diseases. J Cardiovasc Pharmacol (2009) 0.84
Hooke: an open software platform for force spectroscopy. Bioinformatics (2009) 0.84
Placebo manipulations reduce hyperalgesia in neuropathic pain. Pain (2012) 0.84
Mutation of conserved histidines alters tertiary structure and nanomechanics of consensus ankyrin repeats. J Biol Chem (2012) 0.83
A single divergent exon inhibits ankyrin-B association with the plasma membrane. J Biol Chem (2013) 0.83
Identification of sugar isomers by single-molecule force spectroscopy. J Am Chem Soc (2006) 0.83
Experimental designs and brain mapping approaches for studying the placebo analgesic effect. Eur J Appl Physiol (2007) 0.83
Detecting solvent-driven transitions of poly(A) to double-stranded conformations by atomic force microscopy. Biophys J (2009) 0.82